Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Rinsho Shinkeigaku = Clinical Neurology|December 2, 2005
[A case of asymmetric demyelinating neuropathy in a patient with chronic graft-versus-host disease]Hideyuki Matsumoto, Naoko Seki, Tomotaka Yamamoto, et al.Journal of Dental Hygiene : JDH|March 5, 2020
Dental Hygiene Learning Outcomes Obtained Through Computer-Assisted Simulation ModulesNaoko Seki, Janelle Moross, Hiromi Otsuka, et al.Human Immunology|June 29, 2004
Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathyTomasz Bednarczuk, Yuji Hiromatsu, Naoko Seki, et al.Molecular Cancer Therapeutics|June 3, 2010
Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathwaysNaoko Seki, Uhi Toh, Thomas J Sayers, et al.Clinical Oral Investigations|October 26, 2019
The combined effect of light-illuminating direction and enamel rod orientation on color adjustment at the enamel borders of composite restorationsTakashi Hatayama, Yukinori Kano, Asami Aida, et al.Cancer Science|November 2, 2016
Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancerMina Okabe, Uhi Toh, Nobutaka Iwakuma, et al.Cancer Research|January 9, 2003
Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancerNaoko Seki, Yoshihiro Hayakawa, Alan D Brooks, et al.Journal of Dental Sciences|September 30, 2024
An investigation into the cognitive flexibility of undergraduate dental hygiene students at two dental schools in AsiaShin-Ru Liao, Naoko Seki, Richard Foxton, et al.Dental Materials Journal|September 9, 2010
Dentin bond durability and water sorption/solubility of one-step self-etch adhesivesShima Itoh, Masatoshi Nakajima, Keiichi Hosaka, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[The repetitive immune cell transfer therapy combining non-myelosuppressive chemotherapy for patients with advanced and refractory cancer]Uhi Toh, Teruhiko Fujii, Kousuke Tayama, et al.Pageof 5